144 related articles for article (PubMed ID: 9788425)
1. Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of malignant brain-tumor resection-cavity margins.
Dempsey JF; Williams JA; Stubbs JB; Patrick TJ; Williamson JF
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):421-9. PubMed ID: 9788425
[TBL] [Abstract][Full Text] [Related]
2. Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator.
Monroe JI; Dempsey JF; Dorton JA; Mutic S; Stubbs JB; Markman J; Williamson JF
Med Phys; 2001 Jan; 28(1):73-85. PubMed ID: 11213925
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of a novel device for delivering brachytherapy to the margins of resected brain tumor cavities.
Stubbs JB; Frankel RH; Schultz K; Crocker I; Dillehay D; Olson JJ
J Neurosurg; 2002 Feb; 96(2):335-43. PubMed ID: 11838809
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric assessment of an air-filled balloon applicator in HDR vaginal cuff brachytherapy using the Monte Carlo method.
Jiang H; Badkul R; Pokhrel D
J Appl Clin Med Phys; 2018 May; 19(3):101-107. PubMed ID: 29493101
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric effects of saline- versus water-filled balloon applicators for IORT using the model S700 electronic brachytherapy source.
Redler G; Templeton A; Zhen H; Turian J; Bernard D; Chu JCH; Griem KL; Liao Y
Brachytherapy; 2018; 17(2):500-505. PubMed ID: 29229377
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo skin dose simulation in intraoperative radiotherapy of breast cancer using spherical applicators.
Moradi F; Ung NM; Khandaker MU; Mahdiraji GA; Saad M; Abdul Malik R; Bustam AZ; Zaili Z; Bradley DA
Phys Med Biol; 2017 Jul; 62(16):6550-6566. PubMed ID: 28708603
[TBL] [Abstract][Full Text] [Related]
7. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL; Fisher JD; Carson K; Grossman SA;
J Neurosurg; 2003 Aug; 99(2):297-303. PubMed ID: 12924704
[TBL] [Abstract][Full Text] [Related]
8. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
Poon E; Williamson JF; Vuong T; Verhaegen F
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric characterization of a novel intracavitary mold applicator for 192Ir high dose rate endorectal brachytherapy treatment.
Poon E; Reniers B; Devic S; Vuong T; Verhaegen F
Med Phys; 2006 Dec; 33(12):4515-26. PubMed ID: 17278803
[TBL] [Abstract][Full Text] [Related]
10. An indwelling brachytherapy balloon catheter: potential use as an intracranial light applicator for photodynamic therapy.
Hirschberg H; Madsen S; Lote K; Pham T; Tromberg B
J Neurooncol; 1999 Aug; 44(1):15-21. PubMed ID: 10582664
[TBL] [Abstract][Full Text] [Related]
11. Technical Note: Dosimetric impact of spherical applicator size in Intrabeam™ IORT for treating unicentric breast cancer lesions.
Saleh Y; Zhang H
Med Phys; 2017 Dec; 44(12):6706-6714. PubMed ID: 29072347
[TBL] [Abstract][Full Text] [Related]
12. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
Lin L; Patel RR; Thomadsen BR; Henderson DL
Med Phys; 2008 Jan; 35(1):240-7. PubMed ID: 18293579
[TBL] [Abstract][Full Text] [Related]
13. Comparison of
Safigholi H; Meigooni AS; Song WY
Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
[TBL] [Abstract][Full Text] [Related]
15. HDR brachytherapy of rectal cancer using a novel grooved-shielding applicator design.
Webster MJ; Devic S; Vuong T; Han DY; Scanderbeg D; Choi D; Song B; Song WY
Med Phys; 2013 Sep; 40(9):091704. PubMed ID: 24007137
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric optimization of a conical breast brachytherapy applicator for improved skin dose sparing.
Yang Y; Rivard MJ
Med Phys; 2010 Nov; 37(11):5665-71. PubMed ID: 21158278
[TBL] [Abstract][Full Text] [Related]
18. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer.
Vicini FA; Kestin LL; Edmundson GK; Jaffray DA; Wong JW; Kini VR; Chen PY; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):803-10. PubMed ID: 10524437
[TBL] [Abstract][Full Text] [Related]
19. Radiation safety considerations in GliaSite 125I brain implant procedures.
Strzelczyk J; Safadi R
Health Phys; 2004 May; 86(5 Suppl):S120-3. PubMed ID: 15069303
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation.
Chen LX; Liu XW; You RA; Qian JY; Qi ZY; Deng XW; Tsao SY
Med Phys; 2006 Mar; 33(3):761-9. PubMed ID: 16878578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
